A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)
A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)
Not yet recruiting · NCT07418034 · Registry updated 2026-08-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED) | DNA Virus Infections, Disease Attributes, Genital Diseases, Head and Neck Neoplasms, Infections, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pharyngeal Diseases, Stomatognathic Diseases, Tumor Virus Infections, Urogenital Diseases, carcinoma, epithelial neoplasm, head and neck cancer, head and neck squamous cell carcinoma, human papilloma virus infection, infectious disease, neoplasm, oropharyngeal carcinoma, oropharynx squamous cell carcinoma, otorhinolaryngologic disease, sexually transmitted disease, squamous cell carcinoma, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Phase 2 | 2026-08-14 | NCT07418034 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Maryland, Baltimore | 198 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||